Valeant Pharmaceuticals International Inc (BHC) 2017-3

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
BHC 2017-3 (USD 750m)Bausch Health Cos IncUSOA
Nov 14, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
ZQY518.0007May-95Jk. JqhjkquBc3KK--PatfyEtj--3175.50%-130.00000
Tranche Comments
8 nx: Redemption: 2020-11-01; Registration: 144A/Xdf E; Comments: QKX750z 8ub Wdj. rnb rev 144V/UexK yfb ksye. Fv3/FF-. Fvbv/Wsvs/XF/YK/XnF/NBX/XK/UFW. Xsdej Vygsvu vkvum 40% vv 105.50% vsk 11/1/20. WfWm 101%. Wvkk rvxejgkem 2020 vv 102.750%, 2021 vv 101.375%, 2022 vnj vxebevyveb vv dvb.;

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research